Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

herbal science sdn. bhd. - herba leonurus heterophyllus; fructus quercus infectoria; herba labisia pumila; radix pueraria lobata -

United States - English - NLM (National Library of Medicine)

alvogen inc. - amphetamine aspartate monohydrate (unii: o1zpv620o4) (amphetamine - unii:ck833kgx7e), amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e), dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi) - amphetamine aspartate monohydrate 1.25 mg - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. attention deficit hyperactivity disorder (adhd) a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental eff

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - pegaspargase, quantity: 750 u/ml - solution, powder for - excipient ingredients: sucrose; dibasic sodium phosphate; monobasic sodium phosphate; sodium chloride; sodium hydroxide; hydrochloric acid - oncaspar is indicated as a component of antineoplastic combination therapy in patients with acute lymphoblastic leukaemia (all).

Australia - English - Department of Health (Therapeutic Goods Administration)

herbal world pty ltd - turnera diffusa, quantity: 37.5 microgram/ml (equivalent: turnera diffusa, qty 150 microgram/ml; equivalent: beta-arbutin, qty 1.05 microgram/ml); oenothera biennis, quantity: 25 microgram/ml (equivalent: oenothera biennis, qty 100 microgram/ml); dioscorea villosa, quantity: 625 microgram/ml (equivalent: dioscorea villosa, qty 2.5 mg/ml); malpighia glabra, quantity: 82.5 microgram/ml (equivalent: malpighia glabra, qty 825 microgram/ml; equivalent: ascorbic acid, qty 10 microgram/ml); matricaria chamomilla, quantity: 125 microgram/ml (equivalent: matricaria chamomilla, qty 500 microgram/ml) - oral liquid - excipient ingredients: potable water; sodium benzoate; carbon dioxide; sucrose; maltodextrin; citric acid; vanillin; linalool; delta-decalactone; neryl acetate; ethyl propionate; ethyl butyrate; citronellal; anethole; methyl benzoate; buchu leaf oil; dimethyl anthranilate; propylene glycol; phenethyl alcohol; mandarin oil; benzyl acetate; ethyl acetate; ethanol; orange oil; phenylacetaldehyde; cis-3-hexen-1-ol; geraniol; trans-2-hexenol; terpinen-4-ol; limonene; citral; maltol; menthone; ethyl caprate; petitgrain oil; isoamyl acetate; davana oil; rose oil; linalyl acetate; geranyl acetate; bergamot oil; benzaldehyde; l-menthyl acetate; orange flower oil; ethyl enantate; benzyl alcohol; alpha-phellandrene; isovaleric acid; geranyl butyrate; lemon oil terpeneless; cinnamon leaf oil; piperonal; gamma-decalactone; jasmine absolute; ginger oil; terpineol; hexyl acetate; acetic acid; 4-(para-hydroxyphenyl)-2-butanone; decanal; alpha-irone; alpha-terpineol; benzyl benzoate; caprylic aldehyde; butylated hydroxytoluene; nerol; sweet orange oil terpenes and terpenoids; geranyl propionate; gamma-heptalactone; linalyl isobutyrate; ethyl salicylate; 2,6-nonadien-1-ol; dwarf pine-needle oil; ambrette seed oil; methyl anthranilate; dimethyl sulfide; lauryl aldehyde; terpinyl acetate - helps reduce/decrease free radical damage to body cells ; maintain/support cardiovascular system health ; decrease/reduce/relieve diarrhoea ; help maintain/support emotional wellbeing ; decrease/reduce/relieve symptoms of common cold ; decrease/reduce/relieve cough ; decrease/reduce/relieve throat irritation

Australia - English - Department of Health (Therapeutic Goods Administration)

hyperbaric health pty ltd - 12061 - chamber, patient, hyperbaric - a multiplace hyperbaric chamber intended to treat acute and chronic medical conditions. this is achieved by 100% oxygen therapy at more than normal atmospheric pressure

Philippines - English - FDA (Food And Drug Administration)

talan haplacious herbal manufacturer - methyl salicylate,camphor,menthol,eucalyptus oil,herbal extract,mineral oil - liniment - 7 g / 7 g / 5 g / 1 g / qs

Canada - English - Health Canada

homeocan inc. - verbascum thapsus - tablet - 1ch - verbascum thapsus 1ch - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - verbascum thapsus - liquid - 6d - verbascum thapsus 6d - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - verbascum thapsus - liquid - 12d - verbascum thapsus 12d - homeopathic products

Canada - English - Health Canada

total health centre - verbascum thapsus - liquid - 1x - verbascum thapsus 1x - homeopathic products